Ajax Health announced today that it formed and provided funding for Cortex, a new developer of ablation technology for treating AFib.
Cortex launches with $90 million in funding commitments, led by KKR and Hellman & Friedman. AI Life Sciences and other investors also participated in this initial funding. KKR and H&F invested through the Cordis Accelerator, Cordis-X.
The new company brings together expert teams with complementary innovations in electrophysiology, according to a news release. It aims to accelerate the development and clinical validation of next-generation ablation solutions and AFib mapping technology.
The technology coming out of Cortex will be diagnostic and pulsed-field ablation (PFA) catheters. Ablacon’s Electrographic Flow mapping technology will provide comprehensive mapping and navigation capabilities. This mapping helps detect AFib sources, supporting personalized ablation therapy to potentially improve outcomes.
…